Humana Medical Policy Updates – March 2019

Click here to view the Humana Medical Policy Updates Updates »

March 2019 Humana Medical Policy Updates;

• Aldurazyme® (laronidase)
• Allergy Testing
• Ambulatory Cardiac Monitoring Devices
• Angiotensin Blocking Agents
• Angiotensin Blocking Agents
• Angiotensin‐Calcium Channel Blocking Agents
• Artificial Intervertebral Disc Replacement
• Autism Spectrum Disorders (ASD) Diagnosis and Treatment
• Bariatric Surgery
• Bariatric Surgery
• Brovana® (arformoterol inhalation solution)
• Brovana® (arformoterol inhalation solution)
• Cardioverter Defibrillators/Cardiac Resynchronization Therapy
• Continuous Glucose Monitoring Systems
• Continuous Passive Motion (CPM) and Mechanical Stretching Devices
• Continuous Passive Motion (CPM) and Mechanical Stretching Devices
• Discography
• Electric Tumor Treatment Fields
• Epoetin Alfa (Procrit®, Epogen®, Retacrit™)
• Factor IX Replacement Products (Hemophilia B)
• Formulary Tier Exception
• Genetic Testing
• Genetic Testing for Breast and/or Ovarian Cancer Susceptibility
• Genetic Testing for Colorectal Cancer Susceptibility
• Genetic Testing for Diagnosis and Monitoring of Cancer and Molecular Profiling
• Genetic Testing for Diagnosis and Monitoring of Cancer and Molecular Profiling
• Genetic Testing for Marfan Syndrome and Related Conditions
• Hammer Toe Surgical Treatments
• Headache and Occipital Neuralgia Treatments
• High Risk Medications (HRM) in the Elderly
• Khedezla™ (desvenlafaxine ER)
• Ledipasvir‐sofosbuvir
• Nasal Surgical Treatments (Balloon Dilation and Endoscopic)
• Negative Pressure Wound Therapy (NPWT)
• Negative Pressure Wound Therapy (NPWT)
• Orthognathic Surgery
• Orthotics
• Oxandrin® (oxandrolone)
• Oxandrolone
• Pharmacogenomics and Companion Diagnostics
• Prenatal Invasive Diagnostic Genetic Testing
• Prophylactic Mastectomy
• Rytary™ (carbidopa and levodopa extended‐release capsule)
• Short Acting Beta Agonists
• Short Acting Beta Agonists
• Skin and Tissue Substitutes
• Sublocade™ (buprenorphine extended‐release)
• Sublocade™ (buprenorphine extended‐release)
• Topical Testosterone
• Transcatheter Valve Implantation
• Zytiga® (abiraterone)
• Zytiga® (abiraterone)

Click here to view the Humana Medical Policy Updates Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.